Metraipolis › archive › dc_36733adfc9a2

Anticholinergic burden in fibromyalgia treatment analysis: Guidelines adherence and pharmacological alerts — Europe PMC PMID:41990485

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41990485
DOI
10.1016/j.clinsp.2026.100931
License (as archived)
solo-consultazione
Archived
2026-10-08T04:02:10.593Z
SHA-256 of the archived text
4579be9cf2f55aa494996437ba9477c83fbed7fef2fb47348ca0bd38edb5fe75
Stable URL of this page
https://metraipolis.com/documento/dc_36733adfc9a2

How to cite

Anticholinergic burden in fibromyalgia treatment analysis: Guidelines adherence and pharmacological alerts — Europe PMC PMID:41990485 — Europe PMC (en), https://europepmc.org/article/MED/41990485 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_36733adfc9a2 (Metraipolis archive dc_36733adfc9a2, sha256 4579be9cf2f55aa494996437ba9477c83fbed7fef2fb47348ca0bd38edb5fe75)
BibTeX
@misc{dc36733adfc9a2,
  title = {Anticholinergic burden in fibromyalgia treatment analysis: Guidelines adherence and pharmacological alerts — Europe PMC PMID:41990485},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41990485},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_36733adfc9a2; sha256 4579be9cf2f55aa494996437ba9477c83fbed7fef2fb47348ca0bd38edb5fe75},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41990485. Agents can read the archived copy with the MCP tool read_document.